ArticleNature communications2025
Low variability of the Atlantic Meridional Overturning Circulation throughout the Holocene.
Article in Nature communications, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Shifting winter atmospheric teleconnections to the North Pacific reconcile Younger-Dryas and Holocene δNature communications · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
Abstract
Earth system models and paleo-reconstructions indicate that shifts in Atlantic Meridional Overturning Circulation (AMOC) strength profoundly impact global climate. While the last glacial termination experienced large AMOC variations, evidence of AMOC changes during the Holocene are poorly constrained. Here we present a Holocene AMOC reconstruction by quantifying mean bottom water advection strength in the deep North Atlantic. For this, we estimated volumetric flow rates from sedimentary
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.